文献速递临床试验与 GCP基础与转化研究

生活方式干预与来曲唑促排卵治疗多囊卵巢综合征随机对照试验的研究方案

A randomized controlled trial comparing lifestyle intervention to letrozole for ovulation in women with polycystic ovary syndrome: a study protocol.
PubMed 文献 · Trials · 2018-11-16

本研究为随机对照试验,计划纳入240名Rotterdam标准诊断的多囊卵巢综合征(PCOS)不孕女性,比较综合生活方式干预与来曲唑的排卵效果,并进一步随机分配肌醇或安慰剂,主要结局为排卵率,次要结局为受孕。

要点

  • 综合生活方式干预将营养补充、运动及压力管理组合为项目,评估其对PCOS排卵的作用。
  • 来曲唑为对照药物,试验同时析因设计肌醇与安慰剂的附加效果。
  • 主要结局为排卵率,次要结局包括受孕、流产率及生活质量与心理健康评分。

核心结论

  • 该试验将确定结构化生活方式综合干预对PCOS不孕女性排卵的有效性,并评估肌醇补充是否带来额外获益。

研究设计与样本

  • 随机对照试验,计划纳入240名根据Rotterdam标准诊断的PCOS且尝试受孕的女性。
  • 受试者随机分配至综合生活方式干预项目或口服来曲唑,两组再随机分配肌醇或安慰剂。
  • 纳入年龄18至37岁;排除已开始生育治疗、正在或过去3个月内使用肌醇、或正在治疗/有进食障碍史者。

关键数值与推荐

  • 主要结局为排卵率,次要结局为受孕。
  • 其他结局包括流产率、经验证的生活质量评定量表(含社会、关系、身心与情绪子类)及心理健康评分(抑郁、焦虑、压力)。

临床怎么用

  • 若有效,该综合生活方式干预项目可作为PCOS排卵功能障碍的非药物选择,并可能改善其他相关特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polycystic ovary syndrome (PCOS) affects between 8 and 18% of women and is the leading cause of female anovulatory infertility. Unfortunately, common treatments for women trying to conceive can be ineffective as well as disruptive or harmful to patients' quality of life. Despite evidence that women with PCOS have expressed the need for alternative fertility treatments, lifestyle interventions incorporating a nutritional plan with supplementation, increased physical activity, and techniques for stress management have not been combined as a program and studied in this population. Literature suggests that each of these individual components can positively influence reproductive hormones and metabolic health. METHODS/DESIGN: This is a randomized controlled trial which will include 240 women diagnosed with PCOS, according to the Rotterdam criteria, who are trying to conceive. Participants will be randomized to either a comprehensive lifestyle intervention program or prescribed an oral fertility medication, letrozole. These two groups will be further randomized to consume either myo-inositol or a placebo. Participants will be between the ages of 18 and 37 years. Exclusion criteria include women who have already begun fertility treatment, who are currently using myo-inositol or have taken it within the past 3 months, or who are being treated for, or have a history of, an eating disorder. The primary outcome will be the ovulation rate, the secondary outcome will be conception. Other outcomes include miscarriage rates, validated rating measures of overall quality of life (including social, relational, mind/body and emotional sub-categories) and mental health scores (depression, anxiety, and stress). DISCUSSION: This trial will determine the effectiveness of a structured lifestyle-based comprehensive intervention program for women with PCOS experiencing infertility. In addition, it will determine whether supplementing with myo-inositol provides any further benefit. The objective of this study is to assess a possible non-pharmacological solution to ovulatory dysfunction in these patients and perhaps improve other associated features of PCOS. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02630485 . Registered on 15 December 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cutler DA, Shaw AK, Pride SM, et al. A randomized controlled trial comparing lifestyle intervention to letrozole for ovulation in women with polycystic ovary syndrome: a study protocol. Trials. 2018. PMID: 30445999. doi:10.1186/s13063-018-3009-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。